Lytix Biopharma – Update from licensing partner Verrica Pharmaceuticals

  Oslo, November 5th, 2024: Lytix Biopharma, a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, refers

READ MORE

Environmental Factor – March 2019: MOU aims to improve cardiovascular safety of pharmaceuticals

Seeking to improve the cardiovascular safety of pharmaceuticals, the National Toxicology Program (NTP) partnered with the nonprofit Health and Environmental Sciences Institute (HESI) and the

READ MORE

PresVu eye drops claim: DCGI directs FDCA Gujarat to take action against ENTOD Pharmaceuticals

In a follow-up to the suspension of the licence of Mumbai-based pharmaceutical company ENTOD Pharmaceuticals by the Drugs Control General of India (DCGI) last month,

READ MORE

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

Saint-Prex, Switzerland:    This milestone represents significant progress in Ferring’s manufacturing capabilities to meet anticipated growth in demand for Adstiladrin®

READ MORE